Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Handgretinger

Showing results (61-70 of 187) with videos related to

Pageof 19
Sort By:
Cancer Research|July 29, 1998
Targeted therapy with a novel enediyene antibiotic calicheamicin theta(I)1 effectively suppresses growth and dissemination of liver metastases in a syngeneic model of murine neuroblastomaH N Lode, R A Reisfeld, R Handgretinger, et al.
Progress in Clinical and Biological Research|January 1, 1994
Peripheral stem cell transplantation in neuroblastoma stage 4 with the use of [131I-m]IBGT Klingebiel, R Handgretinger, M Herter, et al.
American Journal of Obstetrics and Gynecology|August 1, 1994
CD3+ T cells in first-trimester deciduaJ Dietl, R Handgretinger, H P Horny, et al.
British Journal of Haematology|December 21, 2000
OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplantsP G Schlegel, M Eyrich, P Bader, et al.
Cancer Letters|August 1, 1995
Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic managementT C Carmine, P Evans, G Bruchelt, et al.
Cancer Research|January 1, 1991
Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cellsE Barker, B M Mueller, R Handgretinger, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistryH N Lode, R Handgretinger, U Schuermann, et al.
Cancer Research|November 1, 1990
Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cellsA Kimmig, V Gekeler, M Neumann, et al.
Annals of the New York Academy of Sciences|June 18, 1999
Transplantation of megadoses of purified haploidentical stem cellsR Handgretinger, M Schumm, P Lang, et al.
Experimental Hematology|February 1, 1994
Differential responses of fetal, neonatal, and adult myelopoietic progenitors to interferon and tumor necrosis factorT Hahn, L M Shulman, H Ben-Hur, et al.
Pageof 19

Showing results (61-70 of 187) with videos related to

Sort By:
Pageof 19
Cancer Research|July 29, 1998
Targeted therapy with a novel enediyene antibiotic calicheamicin theta(I)1 effectively suppresses growth and dissemination of liver metastases in a syngeneic model of murine neuroblastomaH N Lode, R A Reisfeld, R Handgretinger, et al.
Progress in Clinical and Biological Research|January 1, 1994
Peripheral stem cell transplantation in neuroblastoma stage 4 with the use of [131I-m]IBGT Klingebiel, R Handgretinger, M Herter, et al.
American Journal of Obstetrics and Gynecology|August 1, 1994
CD3+ T cells in first-trimester deciduaJ Dietl, R Handgretinger, H P Horny, et al.
British Journal of Haematology|December 21, 2000
OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplantsP G Schlegel, M Eyrich, P Bader, et al.
Cancer Letters|August 1, 1995
Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic managementT C Carmine, P Evans, G Bruchelt, et al.
Cancer Research|January 1, 1991
Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cellsE Barker, B M Mueller, R Handgretinger, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistryH N Lode, R Handgretinger, U Schuermann, et al.
Cancer Research|November 1, 1990
Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cellsA Kimmig, V Gekeler, M Neumann, et al.
Annals of the New York Academy of Sciences|June 18, 1999
Transplantation of megadoses of purified haploidentical stem cellsR Handgretinger, M Schumm, P Lang, et al.
Experimental Hematology|February 1, 1994
Differential responses of fetal, neonatal, and adult myelopoietic progenitors to interferon and tumor necrosis factorT Hahn, L M Shulman, H Ben-Hur, et al.
Pageof 19